Clinical Trials in Los Angeles

Showing 521-540 of 16,901 trials

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

NCT04614467

This clinical trial will explore the efficacy and safety of GCSF-mobilized autologous CD34+ cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single administration of CLBS16 or placebo.

Coronary Microvascular DysfunctionCoronary Microvascular DiseaseMicrovascular Coronary Artery Disease

Lisata Therapeutics, Inc.34 participantsStarted Oct 2020

Los Angeles, California, United States • Gainesville, Florida, United States • Hollywood, Florida, United States +4 more locations

RECRUITINGPhase 3< 1 mile

Cefixime Clinical Trial

NCT04958122

This study aims to evaluate the efficacy of cefixime compared to benzathine penicillin G in the treatment of syphilis.

SyphilisHuman Immunodeficiency Virus

University of Southern California400 participantsStarted Jun 2021

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

NCT05815498

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222 (Part 1) and mRNA-1283.815 versus mRNA-1273.815 (Part 2).

COVID-19

ModernaTX, Inc.13,553 participantsStarted Mar 2023

Huntsville, Alabama, United States • Vestavia Hills, Alabama, United States • Chandler, Arizona, United States +227 more locations

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Cefixime Clinical Trial

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

Find Trials by Condition in Los Angeles

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Caring for Dementia Caregivers in Ethnic Immigrant Communities

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

ADH1 and ADH2 Disease Monitoring Study (DMS)

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty